Drugs for TB, hypertension and antacids amongst those failing quality tests

India's Central Drugs Standard Control Organization (CDSCO) flagged 37 batches of medicines for failing quality tests in November, reported livemint.com.

Specifically, a batch of MacLeod Pharmaceuticals' tuberculosis-treating drug Coxerin failed to meet the standards set for "condensation products and assay" tests.

A batch of Intas Pharmaceuticals' acid-reflux combination containing rabeprazole and domperidon failed to meet the criteria set for a dissolution test.

One batch each of Karnataka Antibiotics & Pharmaceuticals, Albro Pharmaceuticals and Elfin Drugs' albendazole also failed dissolution tests.

In addition, a batch of Bengal Chemicals & Pharmaceuticals' amlodipine has also failed the assay test, while one batch of its antibiotic metronidazole also couldn't pass the dissolution test.

Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the reproduced articles,
please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.